Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subcutaneous GAMUNEX-C in Pediatric Primary Immunodeficiency
NCT01465958Phase 4Completed
- Sponsor
- Grifols
- Start
- Nov 2011
- Primary completion
- Oct 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of intravenous immunoglobulin G in primary immunodeficiency (PI), sponsored by Grifols. Started Nov 2011; status: completed.
02
Drugs
intravenous immunoglobulin G
03
Conditions
primary immunodeficiency (PI)
Beyond the preview
Go deeper on NCT01465958.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01465958.